Skip to content

Exposure therapy in virtual reality addressing public speaking anxiety in order increase willingness for in vivo exposure in patients with anxiety disorder and obsessive-compulsive disorder

Exposure therapy in virtual reality addressing public speaking anxiety in order increase willingness for in vivo exposure in patients with anxiety disorder and obsessive-compulsive disorder - Expo-VR-Wil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025154
Enrollment
90
Registered
2021-04-26
Start date
2021-11-18
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F42 F40

Interventions

Group 1: Single session (about 3 hours) exposure therapy in virtual reality (VR) to address public speaking anxiety. The exposure includes a series of speech-related tasks that are natural (e.g., intr

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: • Obsessive-Compulsive Disorder and/or anxiety disorder (MINI criteria) • Gender: male, female • Minimum Age: 18 Years • Maximum Age: 75 Years • Consent to participate in a single VR-session and the diagnostic interviews • Ability to give consent • Sufficient understanding of the German language

Exclusion criteria

Exclusion criteria: • Psychotic symptoms (current or lifetime) • Mania • Severe neuropsychological disease • Current substance dependence • Physical illnesses that are a contraindication to exposures (e.g. heart disease)

Design outcomes

Primary

MeasureTime frame
ERP Feedback Form: Self-report questionnaire to assess willingness to engage in disorder-specific in vivo exposures and to experience unpleasant feelings during these exposures, based on Reid et al. (2017). Patients report their willingness one day before (t1) and one day after (t2) the VR session. Patients' willingness is assessed on a scale ranging from 0 to 100. A further assessment will be at t4.

Secondary

MeasureTime frame
Sudden Units of Distress (SUD): Self-reported assessment of distress (before, during and after the session). Public Speaking Anxiety Scale (PSAS): The PSAS is a self-report questionnaire to assess the extent of behavioral, cognitive and physiological characteristics of public speaking anxiety (t0, t1, t2, t3, t4). Global Assessment of Functioning (GAF): The GAF is a self-report questionnaire to measure the global functioning of patients (t0, t3, t4). Acceptance and Action Questionnaire (AAQ): The AAQ is a self-report questionnaire to assess experiential avoidance (t0, t3, t4). Generalized Anxiety Disorder 7-item (GAD-7): The GAD-7 is a self-report questionnaire to assess the symptom severity of Generalized Anxiety Disorder (t0, t3, t4). Yale-Brown Obsessive Compulsive Scale (Y-BOCS): The Y-BOCS is regarded as gold-standard for the assessment of OCD symptoms and symptom severity during the last week (t0, t3, t4). Obsessive Compulsive Inventory- Revised (OCI-R): The OCI-R is a self-report questionnaire measuring the severity of OCD symptoms (t0 and t3). Obsessive-Beliefs-Questionnaire (OBQ-44): The OBQ is a self-report questionnaire to assess OCD relevant dysfunctional beliefs (t0 and t3). Beck Depression Inventar-II (BDI-II): The BDI is a self-report questionnaire to assess depressive symptoms over the past two weeks (t0, t3, t4). Rosenberg Self-Esteem Scale (RSES): The RSES is a self-report questionnaire to measure self-esteem at t0 and t3. In addition, the version of Kernis (2005) is used at t1 and t2 to capture short-term changes (e.g., patients are asked to give their response based on their emotional state "at that moment" and to rate their response on a scale from 1 (completely disagree) to 10 (completely agree)). Quality of Life - Globalitem (WHO-QOL-BREF): Global item of the self-assessment questionnaire that measures the quality of life (t0, t3, t4). Subjective appraisal Questionnaire: The questionnaire assesses the subjective appraisal of the V

Countries

Germany

Contacts

Public ContactFranziska Miegel

Universitätsklinikum Hamburg-Eppendorf

f.miegel@uke.de+4940741055868

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026